The manufacturers of NeutroSpec voluntarily pulled the radiologic imaging medication from the market in 2005 due to safety concerns. NeutroSpec was used to aid in radiologic imaging in patients 5 years of age and older with unclear signs and symptoms of appendicitis.
What are some important things I should know about NeutroSpec?
NeutroSpec is no longer available in the U.S. The FDA received reports of 2 deaths and more than 15 life-threatening reactions in patients minutes after they were administered the drug. The reactions included shortness of breath, low blood pressure and heart attack.
NeutroSpec was used to aid in radiologic imaging of patients who had unclear signs and symptoms of appendicitis. Patients must be 5 years of age or older. The medication binds to white blood cells. If the patient has appendicitis, there will be an abundance of white blood cells in the appendix.
Appendicitis is an infection of the appendix, which is a part of the large intestine. Appendicitis can lead to a ruptured appendix, which can result in death. Appendicitis is usually recognizable by fever, an elevated white blood count, and pain in the lower right abdomen region. If these signs are not there, NeutroSpec was designed to help doctors determine whether or not is was appendicitis.
NeutroSpec caused adverse, life-threatening reactions in some patients within minutes after being administered. These reactions included shortness of breath, low blood pressure, and pulmonary and cardiac arrest. This led to death in at least 2 patients and serious injury in at least 15.
You should talk to your doctor if you are experiencing heart or lung problems and you were given NeutroSpec. This could mean you have suffered an injury because of NeutroSpec. You should also contact a personal injury attorney in order to discuss your case.
Tags: FDA warning, heart attack, NeutroSpec, radiologic imaging medication